Man held in Britain over contamination of painkillers

British police arrested a man on Friday after anti-psychotic and epilepsy drugs were placed in packets of the painkiller Nurofen Plus, Scotland Yard said.

The case of suspected sabotage last month led to the makers of Nurofen Plus, Reckitt Benckiser, recalling the in Britain and halting their distribution.

A spokesman for London's Metropolitan Police Service said the unnamed 30-year-old man had been arrested in Bromley in the south of the capital on "suspicion of contamination of goods".

"The man is currently being held for questioning at a south London police station," the spokesman told AFP.

Five contaminated packets of Nurofen Plus were found in Britain in August, prompting a national and the recall by the manufacturers.

Four of the affected packs contained XL, an anti-psychotic drug used to treat schizophrenia, mania and bipolar depression, and two people accidentally took the drug but suffered no harm.

The epilepsy drug Neurontin was found in another packet but no one was thought to have taken it.

add to favorites email to friend print save as pdf

Related Stories

Dutch police investigate apparent hacker attack

Dec 10, 2010

(AP) -- Police said Friday they are investigating if hackers were responsible for taking down websites of police and prosecutors in the Netherlands after the arrest of a 16-year-old for involvement in a cyberattack on several ...

British teen arrested over CIA, US Senate hacking

Jun 21, 2011

British police working with the FBI arrested a 19-year-old man over attacks by a hacker group on businesses and government agencies including the CIA, US Senate and Sony, Scotland Yard said Tuesday.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

7 hours ago

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

7 hours ago

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

8 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

8 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments